Bristol-Myers Squibb Company
NYSE: BMY
$59.57
+$0.70 (+1.2%)
Real Time Data Delayed 15 Min.
BMY Stock Chart and Intraday Price
BMY Stock Data
| Asset Type | Stock |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Address | 430 E. 29TH STREET, 14 FLOOR, NEW YORK, NY, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 102,909.25M USD |
| Shares Outstanding | 2,022,190,000 |
BMY Articles
Investors can buy these five top passive income dividend stocks and hold them for the long haul. Top Wall Street firms rate them all at Buy.
Published:
24/7 Wall St. Insights: AbbVie (ABBV) took a big hit after an adult schizophrenia drug missed its primary endpoint in mid-stage trials. Analysts are now questioning the pharma’s pipeline, raising...
Published:
These six high-yield dividend stocks are universally loved by investment professionals and they now offer reasonable entry points.
Published:
Last Updated:
AbbVie has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
Published:
24/7 Wall St. Insights The seemingly endless political season is almost over. It’s possible we won’t know the winner for a while. Sit back and let dividends do the heavy lifting for a simple,...
Published:
Here are three quality blue chip passive income stocks that are still reasonably priced and are rated Buy at top Wall Street firms.
Published:
24/7 Wall St. Insights Baby boomers are overweighted to stocks and stock mutual funds. Growth stocks and risky assets could be crushed in a panic sell-off. Sit back and let dividends do the heavy...
Published:
24/7 Wall St. Insights The 2025 Social Security COLA will be only 2.5%. The COLA increase will equal about $50 per person each month. Sit back and let dividends do the heavy lifting for a simple,...
Published:
Warren Buffett is famous for being a value investor while Peter Lynch tended to be growth-oriented. Some investors are neither, or rather they are a mix of the two as everyone wants to buy a stock at...
Published:
Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what the company's prospects are for the next decade of growth.
Published:
The release of OpenAI‘s ChatGPT chatbot in November 2022 unleashed a frenzy of investor interest in artificial intelligence that propelled Nvidia (NASDAQ:NVDA) to the forefront of the industry. The...
Published:
24/7 Wall St. Insights Dividend stocks are starting to outperform in the second half of 2024. Lower interest rates should be a strong tailwind for companies that pay dependable dividends. Grab our...
Published:
24/7 Wall St. Insights Quality dividend stocks can deliver dependable passive income for years. Dividend stocks could get a big boost as interest rates come down over the next two years. Take...
Published:
The concept of value stocks are easy to understand. In definition, value stocks are stocks that trade below their intrinsic value. Easy enough – that’s what most investors are seeking, after all....
Published:
24/7 Wall St. Insights With inflation starting to be tamed, dividend stocks will be in big demand as rates drop. Quality blue-chip dividend-paying stocks are reliable sources for passive income. Grab...
Published: